Guy Villax

Biography

 Hovione is a global pharmaceutical company with roughly 1,200 employees having its headquarters in the Portuguese capital of Lisbon, where it was established in 1959. The initial research and development of antibiotics and anti-inflammatory agents led the company to later success in selling their products to drug companies and providing services with their original technologies. Hovione began doing business in Japan in the 1960s. In 1987, the company developed and patented dexamethasone*1, which became a bestseller. In 2010, an inhalation device designed and developed by Hovione was licensed for anti-influenza drugs.

Research Interest

 In addition to the first manufacturing plant built in the suburb of Lisbon in 1969, Hovione today has manufacturing plants in the United States, Macau, and Ireland. The development center in Portugal and the United States engage in developing and manufacturing innovative drugs and active pharmaceutical ingredients of high quality that comply with pertinent regulations. In particular, Hovione has a unique capacity to provide comprehensive services related to inhalants extending from chemical synthesis, formulation, to device development. The pioneering company led other companies in research, development, and commercial application of granularity design of active pharmaceutical ingredients by means of spray draying.